Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Dermira Profit Margin 2013-2019 | DERM

Current and historical gross margin, operating margin and net profit margin for Dermira (DERM) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Dermira net profit margin as of March 31, 2019 is -306.91%.
  
Dermira Annual Profit Margins
Dermira Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.502B $0.042B
Dermira, Inc. is a specialty biopharmaceutical company. It is focused on bringing medical dermatology products to dermatologists and their patients. The Company markets topical small molecule therapeutics that target acne, sebaceous gland hyperactivity, and inflammatory skin diseases. Its late-stage product candidates comprise Cimzia which has completed Phase II clinical trials for the treatment of moderate-to-severe plaque psoriasis; DRM04 that is in a Phase IIb clinical trial for the treatment of hyperhidrosis or excessive sweating; and DRM01 which has completed a Phase IIa clinical trial for the treatment of acne. Dermira, Inc. is headquartered in Redwood City, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $60.956B 37.54
Astellas Pharma (ALPMY) Japan $27.265B 13.37
Takeda Pharmaceutical (TAK) Japan $25.795B 8.05
Grifols, S.A (GRFS) Spain $15.271B 19.48
UCB SA (UCBJF) Belgium $15.008B 0.00
Eisai (ESALY) Japan $14.767B 25.39
Merck (MKGAF) Germany $13.532B 18.47
Ionis Pharmaceuticals (IONS) United States $10.137B 21.86
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $9.007B 0.00
Sage Therapeutics (SAGE) United States $8.670B 0.00
IPSEN SA ADR (IPSEY) France $8.634B 0.00
Catalent (CTLT) United States $8.116B 32.57
Jazz Pharmaceuticals (JAZZ) Ireland $7.579B 9.97
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.101B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.071B 18.23
FibroGen (FGEN) United States $3.900B 97.54
United Therapeutics (UTHR) United States $3.630B 0.00
Evotec AG (EVTCY) Germany $3.329B 45.57
Arrowhead Pharmaceuticals (ARWR) United States $3.271B 75.00
Tilray (TLRY) Canada $3.144B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.112B 11.15
Nektar Therapeutics (NKTR) United States $2.981B 0.00
PTC Therapeutics (PTCT) United States $2.739B 0.00
Xencor (XNCR) United States $2.338B 50.99
Zogenix (ZGNX) United States $2.175B 0.00
Portola Pharmaceuticals (PTLA) United States $1.975B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.640B 59.67
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.502B 15.06
Corcept Therapeutics (CORT) United States $1.487B 20.44
Heron Therapeutics (HRTX) United States $1.468B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.436B 23.69
Ironwood Pharmaceuticals (IRWD) United States $1.405B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.227B 0.00
ArQule (ARQL) United States $1.147B 0.00
Aerie Pharmaceuticals (AERI) United States $1.119B 0.00
Radius Health (RDUS) United States $1.098B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.942B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.831B 3.71
Endo (ENDP) Ireland $0.672B 1.18
TherapeuticsMD (TXMD) United States $0.671B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.645B 0.00
Karyopharm Therapeutics (KPTI) United States $0.576B 0.00
Indivior (INVVY) United States $0.546B 1.97
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.542B 0.00
Akebia Therapeutics (AKBA) United States $0.527B 0.00
Concordia (CXRXF) Canada $0.479B 0.00
Aptorum Group (APM) China $0.464B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.445B 0.00
Translate Bio (TBIO) United States $0.445B 0.00
Dova Pharmaceuticals (DOVA) United States $0.442B 0.00
Organogenesis Holdings (ORGO) United States $0.436B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.429B 19.50
Flexion Therapeutics (FLXN) United States $0.426B 0.00
ChemoCentryx (CCXI) United States $0.413B 0.00
ImmunoGen (IMGN) United States $0.408B 0.00
Siga Technologies (SIGA) United States $0.404B 0.95
Collegium Pharmaceutical (COLL) United States $0.400B 0.00
Innate Pharma SA (IPHYF) France $0.374B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.373B 0.00
CV Sciences (CVSI) United States $0.359B 0.00
Harpoon Therapeutics (HARP) United States $0.336B 0.00
Xeris Pharmaceuticals (XERS) United States $0.329B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.325B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.295B 0.00
KalVista Pharmaceuticals (KALV) United States $0.291B 0.00
Rafael Holdings (RFL) United States $0.280B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.280B 0.00
Recro Pharma (REPH) United States $0.277B 0.00
Lannett Co Inc (LCI) United States $0.276B 2.68
OptiNose (OPTN) United States $0.269B 0.00
DURECT (DRRX) United States $0.267B 0.00
CannTrust Holdings (CTST) Canada $0.263B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.254B 0.00
Concert Pharmaceuticals (CNCE) United States $0.249B 0.00
Ocular Therapeutix (OCUL) United States $0.219B 0.00
Ardelyx (ARDX) United States $0.215B 0.00
Calithera Biosciences (CALA) United States $0.213B 0.00
Molecular Templates (MTEM) United States $0.194B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.181B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.181B 0.00
Taiwan Liposome (TLC) Taiwan $0.174B 0.00
Nature's Sunshine Products (NATR) United States $0.174B 29.03
Redhill Biopharma (RDHL) Israel $0.160B 0.00
GlycoMimetics (GLYC) United States $0.151B 0.00
IMV INC (IMV) Canada $0.143B 0.00
Generex Biotechnology (GNBT) United States $0.135B 0.00
Majesco Entertainment (PTE) United States $0.130B 0.00
Jounce Therapeutics (JNCE) United States $0.125B 0.00
MEI Pharma (MEIP) United States $0.120B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.120B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.110B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.109B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
AgeX Therapeutics (AGE) United States $0.104B 0.00
Aquestive Therapeutics (AQST) United States $0.101B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.099B 0.00
Cardiome Pharma (CORV) Canada $0.098B 0.00
Mast Therapeutics (SVRA) United States $0.095B 0.00
Neos Therapeutics (NEOS) United States $0.092B 0.00
Iterum Therapeutics (ITRM) Ireland $0.091B 0.00
Nivalis Therapeutics (ALPN) United States $0.089B 0.00
Genocea Biosciences (GNCA) United States $0.086B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.085B 32.59
MediWound (MDWD) Israel $0.084B 0.00
RENEURON GP (RNUGF) United Kingdom $0.080B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.078B 0.00
Natural Alternatives (NAII) United States $0.077B 7.65
China SXT Pharmaceuticals (SXTC) China $0.072B 0.00
Otonomy (OTIC) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.068B 589.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
Lipocine (LPCN) United States $0.066B 0.00
Infinity Pharmaceuticals (INFI) United States $0.065B 0.00
Novan (NOVN) United States $0.065B 0.00
Capnia (SLNO) United States $0.063B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.061B 0.00
Pharmaxis (PXSLY) Australia $0.060B 0.00
ElectroCore (ECOR) United States $0.054B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.052B 0.00
Medicure (MCUJF) Canada $0.051B 0.00
India Globalization Capital (IGC) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.044B 0.00
CTI BioPharma (CTIC) United States $0.041B 0.00
Aclaris Therapeutics (ACRS) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
Bio-Path Holdings (BPTH) United States $0.035B 0.00
Melinta Therapeutics (MLNT) United States $0.035B 0.00
PharmAthene (ALT) United States $0.033B 0.00
Biomerica (BMRA) United States $0.028B 0.00
ProPhase Labs (PRPH) United States $0.024B 0.00
IsoRay (ISR) United States $0.023B 0.00
Opexa Therapeutics (ACER) United States $0.023B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.017B 1.40
Cyanotech (CYAN) United States $0.016B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.016B 0.00
Achieve Life Sciences (ACHV) United States $0.015B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.015B 0.00
Shineco (TYHT) China $0.014B 0.00
Onconova Therapeutics (ONTX) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
VAXART, INC (VXRT) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.008B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.003B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Xenetic Biosciences (XBIO) United States $0.002B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00